A sequential double blind cross-over trial of tocainide hydrochloride in tinnitus.

Authors
Category Primary study
JournalClinical otolaryngology and allied sciences
Year 1985
A sequential double blind cross-over trial of tocainide hydrochloride, an oral analogue of lignocaine, is reported. The dosage of tocainide hydrochloride ranged from 200-600 mg daily. Of the 32 patients who completed the trial, 1 had complete relief and 2 had partial relief of their tinnitus whilst taking tocainide. An increased incidence of side-effects in patients taking tocainide was noted, in particular, headache, dizziness, nausea and skin rashes.
Epistemonikos ID: 561e5e6689fdc2bee8fe04da47f6d36470c14222
First added on: Sep 10, 2023